Press release
Develop business strategies Of Osteoarthritis - Pipeline Review, H1 2018
About Osteoarthritis Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2018, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581039
Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Osteoarthritis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request for TOC @ https://www.marketresearchreports.biz/reports/1581039/osteoarthritis-pipeline-review-h1-2018-market-research-reports/toc
The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 7, 16, 9, 39 and 13 respectively. Similarly, the Universities portfolio in IND/CTA Filed, Preclinical and Discovery stages comprises 1, 6 and 6 molecules, respectively.
Osteoarthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
View Report @ https://www.marketresearchreports.biz/reports/1581039/osteoarthritis-pipeline-review-h1-2018-market-research-reports
Table of Contents
Table of Contents 2
Introduction 5
Osteoarthritis - Overview 6
Osteoarthritis - Therapeutics Development 7
Osteoarthritis - Therapeutics Assessment 20
Osteoarthritis - Companies Involved in Therapeutics Development 30
Osteoarthritis - Drug Profiles 54
Osteoarthritis - Dormant Projects 205
Osteoarthritis - Discontinued Products 213
Osteoarthritis - Product Development Milestones 214
Appendix 229
List of Tables
Number of Products under Development for Osteoarthritis, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Products under Development by Companies, H1 2018 (Contd..4), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..1), H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Osteoarthritis - Pipeline by 4P-Pharma SAS, H1 2018
Osteoarthritis - Pipeline by Abiogen Pharma SpA, H1 2018
Osteoarthritis - Pipeline by Ablynx NV, H1 2018
Osteoarthritis - Pipeline by Amgen Inc, H1 2018
Osteoarthritis - Pipeline by AVM Biotechnology LLC, H1 2018
Osteoarthritis - Pipeline by Axsome Therapeutics Inc, H1 2018
Osteoarthritis - Pipeline by Biopharm GmbH, H1 2018
Osteoarthritis - Pipeline by Bone Therapeutics SA, H1 2018
Osteoarthritis - Pipeline by Cardax Inc, H1 2018
Osteoarthritis - Pipeline by Cellular Biomedicine Group Inc, H1 2018
Osteoarthritis - Pipeline by Chugai Pharmaceutical Co Ltd, H1 2018
Osteoarthritis - Pipeline by Corestem Inc, H1 2018
Osteoarthritis - Pipeline by Eli Lilly and Co, H1 2018
Osteoarthritis - Pipeline by Endocyte Inc, H1 2018
Osteoarthritis - Pipeline by Ensol Biosciences Inc, H1 2018
Osteoarthritis - Pipeline by Evgen Pharma Plc, H1 2018
Osteoarthritis - Pipeline by Flexion Therapeutics Inc, H1 2018
Osteoarthritis - Pipeline by Galapagos NV, H1 2018
Osteoarthritis - Pipeline by Gemphire Therapeutics Inc, H1 2018
Osteoarthritis - Pipeline by Genequine Biotherapeutics GmbH, H1 2018
Osteoarthritis - Pipeline by GlaxoSmithKline Plc, H1 2018
Osteoarthritis - Pipeline by InKemia IUCT Group SA, H1 2018
Osteoarthritis - Pipeline by International Stem Cell Corp, H1 2018
Osteoarthritis - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2018
Osteoarthritis - Pipeline by K-Stemcell Co Ltd, H1 2018
Osteoarthritis - Pipeline by Kang Stem Biotech Co Ltd, H1 2018
Osteoarthritis - Pipeline by Lateral Pharma Pty Ltd, H1 2018
Osteoarthritis - Pipeline by Levolta Pharmaceuticals Inc, H1 2018
Osteoarthritis - Pipeline by LG Chem Ltd, H1 2018
Osteoarthritis - Pipeline by Marina Biotech Inc, H1 2018
Osteoarthritis - Pipeline by Medivir AB, H1 2018
Osteoarthritis - Pipeline by Merck KGaA, H1 2018
Osteoarthritis - Pipeline by Mesoblast Ltd, H1 2018
Osteoarthritis - Pipeline by Mor Research Application Ltd, H1 2018
Osteoarthritis - Pipeline by Nordic Bioscience A/S, H1 2018
Osteoarthritis - Pipeline by Novartis AG, H1 2018
Osteoarthritis - Pipeline by NovelMed Therapeutics Inc, H1 2018
Osteoarthritis - Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018
Osteoarthritis - Pipeline by Pfizer Inc, H1 2018
Osteoarthritis - Pipeline by Philogen SpA, H1 2018
Osteoarthritis - Pipeline by PhytoHealth Corp, H1 2018
Osteoarthritis - Pipeline by PLx Pharma Inc, H1 2018
Osteoarthritis - Pipeline by ProteoThera Inc, H1 2018
Osteoarthritis - Pipeline by Regulaxis SAS, H1 2018
Osteoarthritis - Pipeline by Rottapharm Biotech Srl, H1 2018
Osteoarthritis - Pipeline by Samumed LLC, H1 2018
Osteoarthritis - Pipeline by Seikagaku Corp, H1 2018
Osteoarthritis - Pipeline by Stelis Biopharma Pvt Ltd, H1 2018
Osteoarthritis - Pipeline by Stempeutics Research Pvt Ltd, H1 2018
Osteoarthritis - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2018
Osteoarthritis - Pipeline by TissueGene Inc, H1 2018
Osteoarthritis - Pipeline by Traverse Biosciences Inc, H1 2018
Osteoarthritis - Pipeline by Unity Biotechnology Inc, H1 2018
Osteoarthritis - Pipeline by Xintela AB, H1 2018
Osteoarthritis - Pipeline by Yooyoung Pharm Co Ltd, H1 2018
Osteoarthritis - Pipeline by Zimmer Biomet Holdings Inc, H1 2018
Osteoarthritis - Dormant Projects, H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..1), H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..2), H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..3), H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..4), H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..5), H1 2018
Osteoarthritis - Dormant Projects, H1 2018 (Contd..6), H1 2018
Osteoarthritis - Discontinued Products, H1 2018
Buy Now @ https://www.researchmoz.com/checkout?rep_id=1581039&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Develop business strategies Of Osteoarthritis - Pipeline Review, H1 2018 here
News-ID: 955849 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Osteoarthritis
Osteoarthritis Market Massive Growth opportunity Ahead
Introduction
Osteoarthritis (OA), the most common form of arthritis, remains a significant global health burden, causing pain, mobility limitations, and reduced quality of life for millions. Driven by an aging population, lifestyle-related factors like obesity, and a growing focus on musculoskeletal health, the osteoarthritis market is witnessing notable transformation.
According to Exactitude Consultancy, the global osteoarthritis market was valued at USD 14 billion in 2024 and is projected to reach USD 22…
Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market: The Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Osteoarthritis Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the osteoarthritis therapeutics market has seen substantial growth. The market size was $8.17 billion in 2024 and is projected to rise to $8.87 billion in 2025, reflecting an annual compound growth rate (CAGR) of 8.6%.…
Osteoarthritis Treatment Market Trends and Forecast 2034
On March 20, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Osteoarthritis Treatment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Osteoarthritis Treatment Market
Introduction
Osteoarthritis (OA) is the most common form of arthritis, affecting millions worldwide. It is a degenerative joint disease that primarily impacts the cartilage and causes pain, stiffness, and reduced mobility. The growing prevalence of osteoarthritis, especially among the aging population, has created a significant demand for treatment options. The osteoarthritis treatment market includes various therapeutic approaches, such as medications, physical therapies, and surgical procedures, designed to manage the symptoms and…
Osteoarthritis Therapeutics Market - Finding Freedom from Osteoarthritis: Discov …
Newark, New Castle, USA: The "Osteoarthritis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Osteoarthritis Therapeutics Market: https://www.growthplusreports.com/report/osteoarthritis-therapeutics-market/7779
This latest report researches the industry structure, sales, revenue,…
Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to In …
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
What the Osteoarthritis Therapeutics Market Looks Like?
The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8…
